Lianxin Liu

8.9k total citations
118 papers, 3.0k citations indexed

About

Lianxin Liu is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Lianxin Liu has authored 118 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 24 papers in Oncology and 23 papers in Hepatology. Recurrent topics in Lianxin Liu's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), RNA modifications and cancer (12 papers) and Liver Disease and Transplantation (9 papers). Lianxin Liu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), RNA modifications and cancer (12 papers) and Liver Disease and Transplantation (9 papers). Lianxin Liu collaborates with scholars based in China, United States and Australia. Lianxin Liu's co-authors include Jiabei Wang, Hongchi Jiang, Tongsen Zheng, Wenwei Hu, Zhaohui Feng, Cen Zhang, Yuhan Zhao, Shangha Pan, Ruipeng Song and Meihua Lin and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Lianxin Liu

111 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianxin Liu China 33 1.3k 591 586 374 333 118 3.0k
Jianfeng Li China 34 1.7k 1.4× 680 1.2× 961 1.6× 381 1.0× 324 1.0× 162 4.7k
Weixing Wang China 32 1.4k 1.1× 633 1.1× 646 1.1× 358 1.0× 816 2.5× 236 4.1k
Wei Wu China 30 1.5k 1.2× 420 0.7× 440 0.8× 468 1.3× 393 1.2× 214 4.0k
Lisong Teng China 33 1.4k 1.1× 758 1.3× 968 1.7× 655 1.8× 617 1.9× 170 3.7k
Jingquan Li China 32 1.6k 1.3× 556 0.9× 845 1.4× 327 0.9× 192 0.6× 125 3.9k
Chen Shao China 33 1.3k 1.0× 632 1.1× 553 0.9× 413 1.1× 220 0.7× 152 4.0k
Xiangyu Zhang China 33 1.6k 1.2× 461 0.8× 407 0.7× 540 1.4× 345 1.0× 180 3.9k
Qiyu Zhang China 29 1.3k 1.0× 429 0.7× 293 0.5× 224 0.6× 516 1.5× 141 3.1k
Ting Xu China 30 1.3k 1.0× 511 0.9× 597 1.0× 375 1.0× 444 1.3× 186 3.4k
Qiuping Liu China 28 1.4k 1.1× 597 1.0× 283 0.5× 308 0.8× 238 0.7× 107 3.4k

Countries citing papers authored by Lianxin Liu

Since Specialization
Citations

This map shows the geographic impact of Lianxin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianxin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianxin Liu more than expected).

Fields of papers citing papers by Lianxin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianxin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianxin Liu. The network helps show where Lianxin Liu may publish in the future.

Co-authorship network of co-authors of Lianxin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Lianxin Liu. A scholar is included among the top collaborators of Lianxin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianxin Liu. Lianxin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Hua, Yao Liu, Jiabei Wang, et al.. (2025). Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis. The EMBO Journal. 44(5). 1414–1441. 3 indexed citations
2.
3.
Zhou, Shuo, Yao Liu, Ning Zhang, et al.. (2025). Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinoma. Cancer Letters. 626. 217774–217774. 2 indexed citations
4.
Wang, Ning, Zebin Zhu, Hao Zheng, et al.. (2024). Diagnosis and Treatment of Hepatic Hematoma After Liver Transplantation in a Timely Manner. Transplantation Proceedings. 56(6). 1390–1395.
5.
Ma, Kun, Yufeng Liu, Yufeng Liu, et al.. (2024). Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced Science. 11(21). e2400676–e2400676. 14 indexed citations
6.
Wang, Jiabei, Yao Liu, Hongyan Zhang, et al.. (2024). HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis. Journal of Advanced Research. 68. 257–270. 6 indexed citations
7.
Meng, Fanzheng, Dalong Yin, Jiabei Wang, et al.. (2024). Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience. Therapeutic Advances in Medical Oncology. 16. 12703130–12703130. 1 indexed citations
8.
9.
Wang, Wei, Wei Cai, Tao Mei, et al.. (2024). Diagnostic value of carbohydrate antigen 50 in biliary tract cancer: A large‐scale multicenter study. Cancer Medicine. 13(12). e7388–e7388. 1 indexed citations
10.
Chen, Kun, Xi Chen, Chuandong Lang, et al.. (2023). CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex. Experimental & Molecular Medicine. 55(9). 2051–2066. 16 indexed citations
11.
Liu, Qian, Li Wang, Wang Dong, et al.. (2023). Ultrahigh Enzyme Loading Metal–Organic Frameworks for Deep Tissue Pancreatic Cancer Photoimmunotherapy. Small. 20(10). e2305131–e2305131. 14 indexed citations
12.
Zhang, Bo, Yunyun Li, Wei Wei, et al.. (2023). Donafenib and GSK‐J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression. Advanced Science. 10(22). e2206798–e2206798. 81 indexed citations
13.
Cai, Wei, et al.. (2023). Retroperitoneal Laparoscopic Hepatectomy for a Subcapsular Hepatocellular Carcinoma in Segment VI (Video). Annals of Surgical Oncology. 30(9). 5450–5451. 1 indexed citations
14.
Shao, Guoliang, Xu Zhu, Weijia Fang, et al.. (2022). Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma. Liver Cancer. 12(2). 116–128. 7 indexed citations
15.
Liang, Shuhang, Hongrui Guo, Kun Ma, et al.. (2021). A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression. Cancer Research. 81(23). 5889–5903. 63 indexed citations
16.
Wei, Hua-xing, Ji Qi, Huan Ma, et al.. (2021). Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis. ACS Sensors. 6(7). 2709–2719. 53 indexed citations
17.
Bu, Wei, Yuanyuan Zheng, Lianxin Liu, Wei-Ping He, & Yu Liu. (2017). Research on Thermodynamic Properties of Resveratrol Analogues Based on QSPR. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Liu, Lianxin, et al.. (2014). Evaluation of quality of teaching based on BP neural network. Journal of chemical and pharmaceutical research. 6(2). 4 indexed citations
19.
Liu, Lianxin, et al.. (2009). Life Assessment and Chloride Ion Diffusivity of Marine Concrete. Journal of Building Materials. 1 indexed citations
20.
Liu, Lianxin, Hongchi Jiang, Anlong Zhu, et al.. (2000). Gene expression profiles in liver cancer and normal liver tissues. World Journal of Gastroenterology. 6. 146–146. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianfeng Li Breakdown of academic impact, for papers by Weixing Wang Breakdown of academic impact, for papers by Wei Wu Breakdown of academic impact, for papers by Lisong Teng Breakdown of academic impact, for papers by Jingquan Li Breakdown of academic impact, for papers by Chen Shao Breakdown of academic impact, for papers by Xiangyu Zhang Breakdown of academic impact, for papers by Qiyu Zhang Breakdown of academic impact, for papers by Ting Xu Breakdown of academic impact, for papers by Qiuping Liu
Rankless by CCL
2026